Expeditors Form 4: Director Mark Emmert sells 4,100 shares at market prices
Rhea-AI Filing Summary
Insider sale by director Mark A. Emmert: On 08/19/2025 Mark A. Emmert, a director of Expeditors International of Washington, Inc. (EXPD), sold 4,100 shares of Expeditors common stock in multiple transactions at a weighted average price of $121.256 per share (individual prices ranged from $121.18 to $121.33). After the sale he beneficially owned 11,868 shares, held directly. The filing includes an undertaking to provide detailed per-trade quantities on request. The Form 4 was signed via attorney-in-fact Diane Heffner on 08/20/2025.
Positive
- Transparency maintained: Form 4 reports specific share counts, weighted average sale price, and offers to provide per-trade details on request.
- Director retains meaningful stake: Post-sale beneficial ownership of 11,868 shares remains, indicating continued alignment with shareholders.
Negative
- Insider sale occurred: Director disposed of 4,100 shares, which is a material reduction in his reported direct holdings.
- No plan disclosure: The filing does not indicate that the sale was made under a Rule 10b5-1 trading plan, so timing appears discretionary.
Insights
TL;DR: A board director executed a routine sale reducing direct holdings by 4,100 shares at market prices.
The transaction appears to be a straightforward open-market sale by a director rather than an option exercise or derivative disposition. The filing states the sale was executed in multiple trades with a weighted average price of $121.256, and the director retains 11,868 shares post-transaction. From a governance perspective, this is a common liquidity event for insiders and not, by itself, evidence of company-specific adverse information. The filing includes the standard undertaking to disclose per-trade quantities upon request, which supports transparency.
TL;DR: Insider sold ~25.7% of reported pre-sale direct holdings, signaling routine portfolio rebalancing.
Based solely on reported numbers, 4,100 shares were disposed leaving 11,868 shares; if those figures reflect the director's total pre-sale position, the sale reduced direct holdings materially in percentage terms. The sale occurred at prices between $121.18 and $121.33, indicating execution at prevailing market levels. No derivatives or other transactions were reported. This is a discrete disclosure event with limited standalone market implication unless accompanied by additional information.